ENDONOVO THERAPEUTICS, INC.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2014 | 162.9M |
| FY2015 | 209.6M |
| FY2016 | 268.7M |
| FY2017 | 633.9M |
| FY2018 | 862.1M |
| FY2019 | 2.4M |
| FY2020 | 49.1M |
| FY2021 | 119.7M |
| FY2022 | 139.2M |
| FY2023 | 270.3M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2014 | 162.9M |
| FY2015 | 209.6M |
| FY2016 | 268.7M |
| FY2017 | 633.9M |
| FY2018 | 862.1M |
| FY2019 | 2.4M |
| FY2020 | 49.1M |
| FY2021 | 119.7M |
| FY2022 | 139.2M |
| FY2023 | 270.3M |